US 11969499
Hydrogel delivery of sting immunotherapy for treatment cancer
granted A61KA61K2039/55561A61K2039/6093
Quick answer
US patent 11969499 (Hydrogel delivery of sting immunotherapy for treatment cancer) held by The Board of Regents of the University of Texas System expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/55561, A61K2039/6093, A61K2039/80, A61K31/7084